BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30160100)

  • 1. A Modified ToxT Inhibitor Reduces Vibrio cholerae Virulence in Vivo.
    Woodbrey AK; Onyango EO; Kovacikova G; Kull FJ; Gribble GW
    Biochemistry; 2018 Sep; 57(38):5609-5615. PubMed ID: 30160100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
    Hung DT; Shakhnovich EA; Pierson E; Mekalanos JJ
    Science; 2005 Oct; 310(5748):670-4. PubMed ID: 16223984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.
    Withey JH; Nag D; Plecha SC; Sinha R; Koley H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7471-6. PubMed ID: 26392502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibitors of toxT expression in Vibrio cholerae.
    Anthouard R; DiRita VJ
    mBio; 2013 Aug; 4(4):. PubMed ID: 23919997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for inhibition of Vibrio cholerae ToxT activity by the unsaturated fatty acid components of bile.
    Plecha SC; Withey JH
    J Bacteriol; 2015 May; 197(10):1716-25. PubMed ID: 25733618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT.
    Mondal SI; Khadka B; Akter A; Roy PK; Sultana R
    Interdiscip Sci; 2014 Jun; 6(2):108-17. PubMed ID: 25172449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal residues of the Vibrio cholerae virulence regulatory protein ToxT involved in dimerization and modulation by fatty acids.
    Childers BM; Cao X; Weber GG; Demeler B; Hart PJ; Klose KE
    J Biol Chem; 2011 Aug; 286(32):28644-55. PubMed ID: 21673111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bicarbonate increases binding affinity of Vibrio cholerae ToxT to virulence gene promoters.
    Thomson JJ; Withey JH
    J Bacteriol; 2014 Nov; 196(22):3872-80. PubMed ID: 25182489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae.
    Shakhnovich EA; Sturtevant D; Mekalanos JJ
    Mol Microbiol; 2007 Dec; 66(6):1331-41. PubMed ID: 17986190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malonate inhibits virulence gene expression in Vibrio cholerae.
    Minato Y; Fassio SR; Häse CC
    PLoS One; 2013; 8(5):e63336. PubMed ID: 23675480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pepA, a gene mediating pH regulation of virulence genes in Vibrio cholerae.
    Behari J; Stagon L; Calderwood SB
    J Bacteriol; 2001 Jan; 183(1):178-88. PubMed ID: 11114915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new class of inhibitors of the AraC family virulence regulator Vibrio cholerae ToxT.
    Woodbrey AK; Onyango EO; Pellegrini M; Kovacikova G; Taylor RK; Gribble GW; Kull FJ
    Sci Rep; 2017 Mar; 7():45011. PubMed ID: 28332578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Virulence of Toxigenic Vibrio cholerae by Anethole through the Cyclic AMP (cAMP)-cAMP Receptor Protein Signaling System.
    Zahid MS; Awasthi SP; Asakura M; Chatterjee S; Hinenoya A; Faruque SM; Yamasaki S
    PLoS One; 2015; 10(9):e0137529. PubMed ID: 26361388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for virulence regulation in
    Cruite JT; Kovacikova G; Clark KA; Woodbrey AK; Skorupski K; Kull FJ
    Commun Biol; 2019; 2():440. PubMed ID: 31815195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The toxbox: specific DNA sequence requirements for activation of Vibrio cholerae virulence genes by ToxT.
    Withey JH; DiRita VJ
    Mol Microbiol; 2006 Mar; 59(6):1779-89. PubMed ID: 16553883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of virulence potential of Vibrio cholerae by natural compounds.
    Yamasaki S; Asakura M; Neogi SB; Hinenoya A; Iwaoka E; Aoki S
    Indian J Med Res; 2011 Feb; 133(2):232-9. PubMed ID: 21415500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fatty Acid Regulator FadR Influences the Expression of the Virulence Cascade in the El Tor Biotype of Vibrio cholerae by Modulating the Levels of ToxT via Two Different Mechanisms.
    Kovacikova G; Lin W; Taylor RK; Skorupski K
    J Bacteriol; 2017 Apr; 199(7):. PubMed ID: 28115548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Cholera Toxin Variant and ToxT Regulon in Environmental
    Neogi SB; Chowdhury N; Awasthi SP; Asakura M; Okuno K; Mahmud ZH; Islam MS; Hinenoya A; Nair GB; Yamasaki S
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30446560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-virulence activity of polyphenolic fraction isolated from Kombucha against Vibrio cholerae.
    Bhattacharya D; Sinha R; Mukherjee P; Howlader DR; Nag D; Sarkar S; Koley H; Withey JH; Gachhui R
    Microb Pathog; 2020 Mar; 140():103927. PubMed ID: 31846743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disarming pathogens--a new approach for antibiotic development.
    Waldor MK
    N Engl J Med; 2006 Jan; 354(3):296-7. PubMed ID: 16421373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.